HVAX Technologies Limited as a company originally incorporated as “HVAX Technologies Private Limited” on November 26, 2010. Initially focused on HVAC project contracting, the company has evolved into a specialized provider of turnkey engineering, procurement, and execution of controlled environment infrastructure and cleanrooms, primarily for the pharmaceutical and healthcare sectors. HVAX also offers design, engineering, consultancy services, and equipment supply. Its clientele extends to chemical companies, hospitals, FMCG companies, and others. The company converted to a public limited company in 2024, expanding its scope and capabilities globally across India, Africa, Asia-Pacific, and the Middle East .

For year/ period ended (Rs. in lacs.)

For year/ period ended ( in Cr.)

• End-to-end Execution Capabilities.
• Visible Growth Through a Robust Order Book.

• Issue-related Expenses.
• General corporate purposes.
• Funding Capital Expenditure

The Company operates in niche EPC segments with great exposure outside Indian market. The company’s revenue and profit increased significantly in last two fiscal years. At upper price INR 458, the company is expected to list at PE of 13.54 which makes valuable company in this segment. So we recommend to subscribe for long term